Dr. Christopher R. Flowers explains that MRD testing varies by cancer type, with results impacting recurrence risk and monitoring based on disease characteristics. Testing for minimal residual disease ...
September 7, 2010 — Hemoglobin variability is common in European hemodialysis patients but does not independently predict mortality, according to the results of a cohort study reported online August ...